CAE appoints Rekha Ranganathan as President, CAE Healthcare

CAE today announced the appointment of Rekha Ranganathan as President of CAE Healthcare, effective immediately. She succeeds Dr. Robert Amyot, who will remain in an advisory capacity to help ensure a smooth transition.

“I am very pleased to welcome Rekha Ranganathan as CAE Healthcare’s new President. Rekha is a proven global business leader with more than 20 years of strategic and operational experience in healthcare and technology,” said Marc Parent, CAE’s President and Chief Executive Officer. “We are privileged to have someone of her calibre join the team and lead CAE Healthcare to the next level, with greater scale and return on investment. Rekha will drive CAE Healthcare’s noble mission to improve patient safety and revolutionize the way healthcare professionals are trained through innovative simulation-based solutions.”

Ms. Ranganathan has a proven track record of driving profitable growth in the healthcare industry, including several leadership positions at Philips Healthtech, a foremost health technology company. Her latest position was Vice President and Global General Manager for Computed Tomography and Advanced Molecular Imaging within the Diagnostic imaging group, where she led all functions. Her international background includes the leadership of the Philips Oncology division based in India as well as the management of commercial and marketing strategy for Boston Scientific USA’s Indian and Chinese markets. Ms. Ranganathan also served in Strategy and Marketing roles at McKinsey.

Ms. Ranganathan holds an MBA from the Wharton School of the University of Pennsylvania, a Master's degree in Mechanical Engineering and Materials Science from the University of California, Berkeley, and a Bachelor’s degree in Metallurgy & Material Science from the Indian Institute of Technology.